Table 1

Key performance indicators (KPIs) used to monitor the implementation of urgent support

KPIMeasure
Risk communication and community engagement
Number of community leaders (key influencers) engaged to share supportive messaging on COVID-19 vaccination.Count of community leaders including traditional and religious leaders engaged.
Number of social media posts to inform about COVID-19 vaccination posted.Count of posts on social media platforms including Facebook, Twitter, Instagram, WhatsApp groups and official websites.
Number of flyers that inform about COVID-19 vaccination distributed among the public.Count of posters bearing the branding of the SLL programme and messages informing the public about COVID-19 vaccination.
Number of live community radio/TV discussions held to inform about COVID-19 vaccination.Count of live community radio/TV discussions held by experts to inform about COVID-19 vaccination.
COVID-19 vaccination centres (CVCs)
Average monthly COVID-19 vaccination coverage in the SLL project areas 6 months prior to commencement of the SLL urgent support.These data enable us determine by how much the SLL urgent support project should have increased vaccination coverage in targeted areas/locations (ie, outcome of interest).
Total number of people targeted for COVID-19 vaccination in all the project intervention areas.A count of persons targeted for vaccination during the SLL urgent support period (ie, during the 3-month period).
Total number of COVID-19 vaccine doses transported by SLL project and received at the CVCs (Disaggregated by vaccine type).Sum of all vaccines received at the SLL-supported CVCs during the SLL urgent support period (ie, during the 3-month period).
First dose: Total number of people vaccinated against COVID-19 over the SLL urgent support implementation period with first dose.First dose only—Total number of first doses for all vaccine types. Includes J&J.
Second dose: Total number of people vaccinated against COVID-19 over the SLL urgent support implementation period with second dose.Second dose only—Total number of second doses for all vaccine types. Excludes J&J.
Total number of COVID-19 vaccine doses administeredSum of first dose+second dose+J&J: Vaccine doses used during the SLL urgent support implementation period.
Total number of persons vaccinated against COVID-19Sum of persons who have been fully vaccinated, ie, have received first dose+second dose for two-dose regime vaccines) plus those that have received a J&J vaccine.
Total number of COVID-19 vaccine doses wasted (Disaggregated by vaccine type)Sum of all vaccine types wasted. Wastage defined as: vial breakage during transportation, pilferage, expiry, etc.
Number of ancillary products for COVID-19 vaccines (PPE, syringes, needles, sanitiser, sterile wipes, swabs, cotton, plasters, and medical waste disposal) purchased.Count of ancillary products for COVID-19 vaccines purchased.
Number of ancillary products for COVID-19 vaccines distributed.Count of ancillary products for COVID-19 vaccines received at CVCs.
Number of new CVCs set up and functional (ie, administering vaccine doses).Count of new CVC sites (fixed and mobile teams) set up and functional (ie, administering COVID-19 vaccine doses).
Number of existing CVCs in the MS with low vaccine uptake strengthened.Count of existing CVCs in the Member States with low vaccine uptake supported with either cold chain equipment, vaccine supplies, or CHWs, etc.
Number of CHWs trained to support existing CVCs.Count of CHWs trained to support existing CVCs as either as vaccinators, data managers, or infection prevention and control staff.
  • CHWs, community health workers; MS, Member States; PPE, personal protective equipment.